| PET and PET-CT imaging of gynecological malignancies: present role and future promise. | |
| | |
MedLine Citation:
|
PMID: 19105709 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In this article, we have reviewed the current role of PET/PET-computed tomography (CT) in the management of gynecological malignancies. The promise of this technique is becoming increasingly evident, based upon several studies conducted in these malignancies. 2-fluoro-2-deoxy-D-glucose-PET appears to have a potential role in assessing response to treatment and forecasting prognosis. For cervical carcinoma, the modality has proven useful in both the staging of untreated advanced cervical cancer and restaging of the disease. Its role in prognostication of the disease and in detecting lesions in the setting of post-treatment unexplained tumor-marker elevation appears promising. PET is of great benefit as a diagnostic tool in ovarian carcinoma when there is an increase in serum CA-125 and CT/MRI or conventional imaging are inconclusive or negative. With regard to its role in endometrial carcinoma, its benefit is particularly emphasized in the setting of post-therapy surveillance of the disease, although, in a limited series, it also appears to give additional information in the pretreatment states. PET may be of value in detecting the extra-uterine lesions that are not visualized with CT/MRI. Data on the role of 2-fluoro-2-deoxy-D-glucose-PET imaging in the management of vulvar and vaginal cancer are relatively sparse at this time but the modality appears to be of value in staging disease and is more effective than conventional diagnostic modalities with respect to detecting nodal metastasis in both malignancies. |
| | |
Authors:
|
Sandip Basu; Geming Li; Abass Alavi |
Related Documents
:
|
17198889 - Integrated ct-pet imaging of esophageal cancer: unexpected and unusual distribution of ... 18719909 - Diagnostic value of pet/ct for the staging and restaging of pediatric tumors. 10397709 - Whole-body positron emission tomography using 18f-fluorodeoxyglucose for posttreatment ... 18694659 - A review of diagnostic imaging in melanoma. 16724209 - Evaluation of the impact of addition of pet to ct and mr scanning in the staging of pat... 7835779 - Pelvic staging of advanced and recurrent gynecologic cancers: contribution of endosonog... 17493539 - Imaging in spinal vascular disease. 18237769 - Progressive moyamoya syndrome associated with de novo formation of the ipsilateral veno... 22071649 - Lumbar vertebral hemangioma with extradural extension, causing neurogenic claudication:... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Expert review of anticancer therapy Volume: 9 ISSN: 1744-8328 ISO Abbreviation: Expert Rev Anticancer Ther Publication Date: 2009 Jan |
Date Detail:
|
Created Date: 2008-12-24 Completed Date: 2009-03-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101123358 Medline TA: Expert Rev Anticancer Ther Country: England |
Other Details:
|
Languages: eng Pagination: 75-96 Citation Subset: IM |
Affiliation:
|
Radiation Medicine Centre, Tata Memorial Hospital Annexe, Parel, Bombay, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Female Genital Neoplasms, Female / pathology, radiography*, radionuclide imaging* Humans Magnetic Resonance Imaging Positron-Emission Tomography Prognosis Tomography, X-Ray Computed |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cancer vaccines: will we ever learn?
Next Document: RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells.